494771-03-8

Basic information

• Product Name: 1-[19-amino-5-sec-butyl-8-(2-carbamoyl-ethyl)-11-carbamoylmethyl-2-(4-hydroxy-benzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13pentaaza-cycloeicos-16-ene-14-carbonyl]-pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide
• Synonyms: 1-[19-amino-5-sec-butyl-8-(2-carbamoyl-ethyl)-11-carbamoylmethyl-2-(4-hydroxy-benzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13pentaaza-cycloeicos-16-ene-14-carbonyl]-pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide
• CAS NO: 494771-03-8
• Molecular Weight: 969.108
• Mol File: 494771-03-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-[19-amino-5-sec-butyl-8-(2-carbamoyl-ethyl)-11-carbamoylmethyl-2-(4-hydroxy-benzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13pentaaza-cycloeicos-16-ene-14-carbonyl]-pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[19-amino-5-sec-butyl-8-(2-carbamoyl-ethyl)-11-carbamoylmethyl-2-(4-hydroxy-benzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13pentaaza-cycloeicos-16-ene-14-carbonyl]-pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide(494771-03-8)
• EPA Substance Registry System: 1-[19-amino-5-sec-butyl-8-(2-carbamoyl-ethyl)-11-carbamoylmethyl-2-(4-hydroxy-benzyl)-3,6,9,12,20-pentaoxo-1,4,7,10,13pentaaza-cycloeicos-16-ene-14-carbonyl]-pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide(494771-03-8)

Safety Data

• Hazardous Substances Data: 494771-03-8(Hazardous Substances Data)

Upstream product

• 71989-23-6 Fmoc-Ile-OH 
• 71989-38-3 Fmoc-Tyr(tBu)-OH 
• 132327-80-1 Fmoc-L-Gln(Trt)-OH 
• 146549-21-5 2-(9H-fluoren-9-ylmethoxycarbonylamino)-pent-4-enoic acid 

Relevant articles and documents

Synthesis of biologically active dicarba analogues of the peptide hormone oxytocin using ring-closing metathesis.

Facile synthesis of cis and trans olefinic analogues of oxytocin 1 that have carbon in place of sulfur is achieved via ring-closing metathesis (RCM) on a resin-bound linear precursor peptide. Hydrogenation of the cis olefin, 3, proceeds selectively to gen